Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page
- Check7 days agoChange DetectedA new history entry Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSponsor name updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company, replacing Karuna Therapeutics.SummaryDifference0.2%

- Check36 days agoChange DetectedA new revision entry, v3.5.0, was added. The previous revision, v3.4.3, was removed from the Record History.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed from view.SummaryDifference0.1%

- Check71 days agoChange DetectedNew Revision: v3.4.2 added to the history and the temporary government-funding status notice (v3.4.1) was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check78 days agoChange DetectedSite-wide funding notice was added and the record version updated to v3.4.1, replacing v3.4.0. These are minor metadata updates and do not affect study data, eligibility, or results.SummaryDifference0.8%

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.